Palomino Laboratories (PALX) Gains from Investment Securities (2025)

Palomino Laboratories' (PALX) quarterly Gains from Investment Securities came in at $1.5 million in Q3 2025, down 25.0% quarter-over-quarter from $2.0 million in Q1 2025.

Palomino Laboratories (PALX) Gains from Investment Securities (2025) Analysis & Trends

Palomino Laboratories has disclosed Gains from Investment Securities across 1 years of filings, most recently posting $1.5 million for Q3 2025.

  • Gains from Investment Securities for Q3 2025 came in at $1.5 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $1.5 million (changed N/A YoY), and the FY2024 annual result was $58.0, changed 0.0% from the prior year.
  • Gains from Investment Securities came in at $1.5 million for Q3 2025 at Palomino Laboratories, down from $2.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.0 million in Q1 2025 to a low of $1.5 million in Q3 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 1.50 Mn
Sep 30, 2025 1.50 Mn
Mar 31, 2025 2.00 Mn
Mar 31, 2025 2.00 Mn